Analysis
| Earnings estimate |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Sep 2026) |
Next year (Sep 2027) |
|---|---|---|---|---|
| Number of analysts | 30 | 28 | 39 | 37 |
| Average estimate | 2.66 | 1.84 | 8.23 | 9.08 |
| Low estimate | 2.51 | 1.70 | 7.76 | 8.30 |
| High estimate | 2.80 | 2.15 | 8.88 | 10.06 |
| Last year EPS | 2.40 | 1.65 | 7.46 | 8.23 |
| Revenue estimate |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Sep 2026) |
Next year (Sep 2027) |
|---|---|---|---|---|
| Number of Analysts | 29 | 28 | 38 | 39 |
| Avg. estimate | 138.02B | 104.52B | 452.51B | 480.44B |
| Low estimate | 136.68B | 98.91B | 437.29B | 444.29B |
| High estimate | 140.67B | 109.16B | 466.44B | 526.33B |
| Last year sales | 124.30B | 95.36B | 416.16B | 452.51B |
| Sales growth | 0.11 | 0.10 | 0.09 | 0.06 |
| EPS trend |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Sep 2026) |
Next year (Sep 2027) |
|---|---|---|---|---|
| Current estimate | 2.66 | 1.84 | 8.23 | 9.08 |
| 7 days ago | 2.66 | 1.84 | 8.23 | 9.08 |
| 30 days ago | 2.49 | 1.80 | 7.99 | 8.81 |
| 60 days ago | 2.47 | 1.79 | 7.96 | 8.76 |
| 90 days ago | 2.48 | 1.78 | 7.97 | 8.80 |
| EPS revisions |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Sep 2026) |
Next year (Sep 2027) |
|---|---|---|---|---|
| Up last 7 days | 16 | 13 | 26 | 14 |
| Up last 30 days | 18 | 16 | 30 | 13 |
| Down last 7 days | 0 | 0 | 0 | 0 |
| Down last 30 days | 1 | 5 | 4 | 3 |
| Growth estimates | |
|---|---|
| Current qtr (Nov 2025) | 0.108% |
| Next qtr. (Feb 2026) | 0.113% |
| Current year (2025) | 0.100% |
| Next 5 years (per annum) | 0.146% |
| Past 5 years (per annum) | 0.204% |
Recommendation
Buy